Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

200%

2 of 1 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03616990Not ApplicableActive Not Recruiting

Supportive Release Center Study

Role: collaborator

NCT00725270Phase 2Terminated

Treatment of Schizoaffective Disorder Using Mifepristone

Role: collaborator

NCT01210651Not ApplicableCompleted

Treating Major Depression With Yoga: A Prospective, Randomized Controlled Pilot Trial

Role: collaborator

All 3 trials loaded